SOLV
Solventum Corp
NYSE · Healthcare · Medical - Care Facilities · US
$85.05
−0.89%Oct 19, 2026, 20:05 UTC
The U.S. Food and Drug Administration granted 510(k) clearance for the combined use of Solventum Corp’s Restrata Synthetic Electrospun Fiber Matrix and V.A.C. Therapy.
Source:Oct 15, 2026, 20:05 UTC
Solventum Corp announced that it will release its third-quarter fiscal 2026 financial results on November 5, 2026, after U.S. financial markets close.
Source:Oct 12, 2026, 15:24 UTC
Solventum Corp is collecting offers for its Solventum Corp.
Source:Sep 24, 2026, 02:01 UTC
Aso International fully launched its AIS (Aso Indirect bonding System) digital lingual orthodontic appliance system in summer 2026, succeeding Solventum's discontinued Incognito system.
Source:Sep 9, 2026, 15:55 UTC
Solventum announced plans to separate its Healthcare Information Services business, with the final path and timing not yet determined.
Source:Aug 5, 2026, 20:12 UTC
Solventum reported its second quarter 2026 financial results, with reported sales up 2.2% and organic sales up 9.5%.
Aug 5, 2026, 20:05 UTC
Solventum announced its intention to separate its Health Information Systems business as part of its portfolio optimization strategy.